Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

195,388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Six Versus 12 Months of Dual Antiplatelet Therapy After Implantation of Biodegradable Polymer Sirolimus-Eluting Stent: Randomized Substudy of the I-LOVE-IT 2 Trial.
Han Y, Xu B, Xu K, Guan C, Jing Q, Zheng Q, Li X, Zhao X, Wang H, Zhao X, Li X, Yu P, Zang H, Wang Z, Cao X, Zhang J, Pang W, Li J, Yang Y, Dangas GD. Han Y, et al. Among authors: li j, li x. Circ Cardiovasc Interv. 2016 Feb;9(2):e003145. doi: 10.1161/CIRCINTERVENTIONS.115.003145. Circ Cardiovasc Interv. 2016. PMID: 26858080 Clinical Trial.
Impact of six versus 12 months of dual antiplatelet therapy in patients with drug-eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I-LOVE-IT 2 trial.
Qiu M, Li Y, Li J, Xu K, Jing Q, Dong S, Jin Z, Zhao P, Xu B, Han Y. Qiu M, et al. Among authors: li y, li j. Catheter Cardiovasc Interv. 2017 Mar;89(S1):565-573. doi: 10.1002/ccd.26948. Epub 2017 Feb 17. Catheter Cardiovasc Interv. 2017. PMID: 28211603 Clinical Trial.
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.
Han Y, Guo J, Zheng Y, Zang H, Su X, Wang Y, Chen S, Jiang T, Yang P, Chen J, Jiang D, Jing Q, Liang Z, Liu H, Zhao X, Li J, Li Y, Xu B, Stone GW; BRIGHT Investigators. Han Y, et al. Among authors: li y, li j. JAMA. 2015 Apr 7;313(13):1336-46. doi: 10.1001/jama.2015.2323. JAMA. 2015. PMID: 25775052 Clinical Trial.
Efficiency and safety of bivalirudin in patients undergoing emergency percutaneous coronary intervention via radial access: A subgroup analysis from the bivalirudin in acute myocardial infarction versus heparin and GPI plus heparin trial.
Wang H, Li Y, Cong H, Ding S, Liu B, Li L, Chen Y, Jia S, Jing Q, Zhao X, Liu H, Liang Z, Li J, Bao D, Han Y. Wang H, et al. Among authors: li y, li j, li l. Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1157-1165. doi: 10.1002/ccd.26804. Epub 2016 Sep 28. Catheter Cardiovasc Interv. 2017. PMID: 27677411 Clinical Trial.
Short-term rosuvastatin treatment for the prevention of contrast-induced acute kidney injury in patients receiving moderate or high volumes of contrast media: a sub-analysis of the TRACK-D study.
Zhang J, Li Y, Tao GZ, Chen YD, Hu TH, Cao XB, Jing QM, Wang XZ, Ma YY, Wang G, Liu HW, Wang B, Xu K, Li J, Deng J, Han YL. Zhang J, et al. Among authors: li y, li j. Chin Med J (Engl). 2015 Mar 20;128(6):784-9. doi: 10.4103/0366-6999.152620. Chin Med J (Engl). 2015. PMID: 25758273 Free PMC article. Clinical Trial.
Short-term rosuvastatin therapy for prevention of contrast-induced acute kidney injury in patients with diabetes and chronic kidney disease.
Han Y, Zhu G, Han L, Hou F, Huang W, Liu H, Gan J, Jiang T, Li X, Wang W, Ding S, Jia S, Shen W, Wang D, Sun L, Qiu J, Wang X, Li Y, Deng J, Li J, Xu K, Xu B, Mehran R, Huo Y. Han Y, et al. Among authors: li y, li j, li x. J Am Coll Cardiol. 2014 Jan 7-14;63(1):62-70. doi: 10.1016/j.jacc.2013.09.017. Epub 2013 Sep 26. J Am Coll Cardiol. 2014. PMID: 24076297 Free article. Clinical Trial.
195,388 results
You have reached the last available page of results. Please see the User Guide for more information.